6 programs reviewed
In short: 6 online programs prescribe Ozempic. The cheapest starts at $149 a month (Gala GLP-1), the highest rated scores 76 of 100 (Gala GLP-1), and 1 of 6 accept insurance. Every starting price rises as the dose does.
Ozempic is approved for type 2 diabetes. Prescribing it for weight loss is off-label. That is lawful and common, and it is why insurance so often declines it. If weight is the goal and coverage matters, Wegovy is usually the product being looked for, even when Ozempic is the name searched.
Fewer online programs dispense Ozempic than the search volume suggests. Most weight-focused telehealth writes for Wegovy, or compounds semaglutide instead. The programs below will consider it, with what each charges when a plan does not pay.
Sorted cheapest first. The score beside each is the overall research rank, so a program that is cheap and poorly rated shows as both. Starting prices are what a program publishes to begin, and every one of them rises as the dose does.
A women-focused program with published compounded and brand-name starting prices
4.6/5 · 3,886BBB · Not matchedOverall score
83/100 transparency
Visit Gala GLP-1 We may earn a commission from this link at no additional cost to you.
Bills participating insurance and covers brand-name, compounded, and non-GLP-1 paths
3.9/5 · 709BBB · 85 complaintsOverall score
86/100 transparency
Visit Found We may earn a commission from this link at no additional cost to you.
Named clinicians and pharmacy partners with national program availability
Overall score
87/100 transparency
A streamlined cash-pay program whose official prices vary by page
3.6/5 · 5,404BBB · Under reviewOverall score
74/100 transparency
Strong brand-name options with insurance-navigation support
3.8/5 · 4,572BBB · 617 complaintsOverall score
91/100 transparency
A broad medication menu with an asynchronous-first experience
3.0/5 · 8,819BBB · 4,244 complaintsOverall score
82/100 transparency
A plan covering Ozempic for diabetes will frequently refuse it for weight. Ask the program what it does when prior authorization is declined.
Same molecule, approved for weight, and usually the easier authorization. Worth asking whether the program will write for it instead.
Without coverage the list price is high enough that compounded semaglutide is what most cash-pay patients end up on. Compare both before deciding.
Some of the programs above will consider it. Prescribing Ozempic for weight loss is off-label — it is approved for type 2 diabetes. That is lawful and common, and it is why insurance declines it for that use.
Usually, yes. Wegovy is the same molecule approved for chronic weight management, which makes authorization easier. If weight is the goal and coverage matters, it is worth asking whether the program will write for Wegovy.
The published starting prices are in the table above. Without coverage the approved product is expensive enough that most cash-pay patients end up on compounded semaglutide instead. Compare both routes before deciding.
No. It shares the active ingredient but is prepared by a pharmacy rather than manufactured and reviewed as a finished product, and the FDA has warned about unapproved GLP-1 products sold for weight loss.
Sources
Program facts come from each provider's own published pages, dated on the review. This site does not provide medical advice.
Each of these sorts the programs prescribing it by starting price, the same way this one does.
What an evaluation requires, and how the approved product differs from a compounded one.
Compare medical weight loss clinics near you, with the clinician named on each listing.
The full ranking across every medication, scored on evidence rather than price alone.
